Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00315757
Status:
COMPLETED
Last Update Posted:
2013-08-08
First Post:
2006-04-17
Brief Title:
Study of Mapatumumab in Combination With Bortezomib Velcade and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Human Genome Sciences Inc
Organization:
Human Genome Sciences Inc
Organization Data
Organization:
Human Genome Sciences Inc
Class:
INDUSTRY
Study ID:
HGS1012-C1055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Human Genome Sciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None